Table 1 Phase 1 clinical trial outcomes at 6 months CGA10

From: The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity

 

Placebo

1.5 mg/kg

5 mg/kg

# infants with respiratory re-hospitalizations at 6 months CGA

3/6

0/6

0/5

# infants using bronchodilators at 6 months CGA

5/6

0/6

0/5

# deaths

0/7

1/8

1/7

  1. Denominators are numbers of infants with the available data
  2. CGA corrected gestational age
Back to article page